Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Free Cash Flow (2019 - 2025)

Korro Bio's Free Cash Flow history spans 7 years, with the latest figure at -$17.8 million for Q4 2025.

  • For the quarter ending Q4 2025, Free Cash Flow fell 98.79% year-over-year to -$17.8 million, compared with a TTM value of -$79.1 million through Dec 2025, down 1.41%, and an annual FY2025 reading of -$79.1 million, down 1.41% over the prior year.
  • Free Cash Flow for Q4 2025 was -$17.8 million at Korro Bio, down from -$17.4 million in the prior quarter.
  • The five-year high for Free Cash Flow was -$8.9 million in Q4 2024, with the low at -$27.5 million in Q1 2024.
  • Average Free Cash Flow over 5 years is -$18.5 million, with a median of -$17.9 million recorded in 2021.
  • Year-over-year, Free Cash Flow tumbled 180.92% in 2021 and then soared 60.69% in 2024.
  • Tracing KRRO's Free Cash Flow over 5 years: stood at -$17.9 million in 2021, then grew by 9.95% to -$16.2 million in 2022, then plummeted by 40.83% to -$22.8 million in 2023, then soared by 60.69% to -$8.9 million in 2024, then crashed by 98.79% to -$17.8 million in 2025.
  • Per Business Quant, the three most recent readings for KRRO's Free Cash Flow are -$17.8 million (Q4 2025), -$17.4 million (Q3 2025), and -$19.4 million (Q2 2025).